← Back to list
Home Hemoglobin Testing Devices (CPB 0824, reviewed 2025-12-09)
Effective date
Not stated in the notice
Identified
Aug 18, 2026
Summary
Aetna considers home hemoglobin testing devices experimental, investigational, or unproven for the management of chronic anemia and all other indications because their effectiveness has not been established. The policy states that there is a lack of evidence demonstrating that self-monitoring of hemoglobin would result in improved health outcomes in persons with chronic anemia.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
Get Aetna alertsPolicy Monitoring is free. No card required.
What to do
Action · 3 steps
01There is no specific CPT or HCPCS code for home hemoglobin testing devices.
02ICD-10 codes D50.0 through D64.9 (anemias) are listed as not covered for the indications in this policy.
03Home hemoglobin testing devices are considered experimental, investigational, or unproven for the management of chronic anemia and all other indications, so they should not be billed as covered services for these indications.
Codes mentioned
D50.0D64.9
Original notice
Home Hemoglobin Testing Devices (CPB 0824, reviewed 2025-12-09)
aetna.com · Always check the source before changing claims.
Related changes
See all Aetna changes →Helicobacter Pylori Infection Testing (CPB 0177, reviewed 2026-03-20)MediumNo effective date · Medical PolicyNon-myeloablative Hematopoietic Cell Transplantation (Mini-Allograft / Reduced Intensity Conditioning Transplant) (CPB 0634, reviewed 2026-09-25)MediumNo effective date · Medical PolicyLead Testing (CPB 0553, reviewed 2026-08-28)MediumNo effective date · Medical PolicyHematopoietic Cell Transplantation for Aplastic Anemia and other Bone Marrow Failure Syndromes (CPB 0627, reviewed 2026-09-23)MediumNo effective date · Medical PolicyBrowse every Aetna change in the policy list